ArticleVeterinary medicine and science2025
Therapeutic Effect of Barberry (Berberis vulgaris) Root Extract on Experimental Cutaneous Leishmaniosis in a BALB/c Mouse Model.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic Effect of Barberry (Berberis vulgaris) Root Extract on Experimental Cutaneous Leishmaniosis in a BALB/c Mouse Model.Veterinary medicine and science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bioactive compounds derived from plants offer promising avenues for discovering new treatments for various types of leishmaniasis. Approximately 22 alkaloids have been identified in different parts of the barberry plant, particularly in the roots. This study aimed to investigate the therapeutic effects of barberry (Berberis vulgaris) on the treatment of experimental cutaneous leishmaniasis (CL) caused by Leishmania major in a BALB/c mouse by using pathological, immunohistochemical, and clinical methods. Thirty BALB/c mice, aged 6-8 weeks, were purchased from the Razi Animal Laboratory at Karaj Institute and allowed for adaptation by 1 week. The mice were divided into three groups including control, treatment, and vehicle groups. Animals of both treatment and vehicle groups received a subcutaneous injection of 0.1 mL culture medium containing 2 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.